39,828 Shares in Corteva, Inc. (NYSE:CTVA) Purchased by Mediolanum International Funds Ltd

Mediolanum International Funds Ltd purchased a new stake in Corteva, Inc. (NYSE:CTVA - Free Report) in the first quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund purchased 39,828 shares of the company's stock, valued at approximately $2,270,000.

Several other institutional investors have also made changes to their positions in the stock. Redmont Wealth Advisors LLC acquired a new position in shares of Corteva in the first quarter valued at approximately $25,000. Rise Advisors LLC lifted its stake in Corteva by 2,522.2% in the first quarter. Rise Advisors LLC now owns 472 shares of the company's stock valued at $27,000 after purchasing an additional 454 shares during the last quarter. Albion Financial Group UT grew its stake in Corteva by 77.2% in the 1st quarter. Albion Financial Group UT now owns 505 shares of the company's stock valued at $29,000 after buying an additional 220 shares in the last quarter. CVA Family Office LLC purchased a new stake in shares of Corteva in the fourth quarter worth about $25,000. Finally, Ironwood Wealth Management Inc. increased its holdings in shares of Corteva by 106.1% in the first quarter. Ironwood Wealth Management Inc. now owns 544 shares of the company's stock worth $31,000 after purchasing an additional 280 shares during the period. 81.54% of the stock is currently owned by institutional investors.

Analyst Ratings Changes

CTVA has been the subject of several recent analyst reports. Barclays boosted their target price on Corteva from $55.00 to $58.00 and gave the stock an "equal weight" rating in a research report on Wednesday, April 10th. JPMorgan Chase & Co. reaffirmed a "neutral" rating and issued a $57.00 target price (down from $58.00) on shares of Corteva in a research note on Friday, April 12th. Royal Bank of Canada boosted their price target on shares of Corteva from $62.00 to $64.00 and gave the stock an "outperform" rating in a research note on Monday, May 6th. OTR Global restated a "negative" rating on shares of Corteva in a research report on Friday, June 7th. Finally, Deutsche Bank Aktiengesellschaft reiterated a "buy" rating and issued a $65.00 target price on shares of Corteva in a research report on Wednesday, June 12th. One research analyst has rated the stock with a sell rating, six have given a hold rating and fifteen have issued a buy rating to the company's stock. According to data from MarketBeat.com, the company currently has an average rating of "Moderate Buy" and an average target price of $63.00.

Corteva Trading Up 2.5 %

NYSE CTVA traded up $1.25 on Thursday, hitting $52.27. The company's stock had a trading volume of 2,160,610 shares, compared to its average volume of 3,514,562. The company has a current ratio of 1.51, a quick ratio of 0.97 and a debt-to-equity ratio of 0.10. Corteva, Inc. has a 52-week low of $43.22 and a 52-week high of $58.76. The firm has a market cap of $36.43 billion, a P/E ratio of 64.58, a PEG ratio of 1.38 and a beta of 0.77. The company's 50-day simple moving average is $54.34 and its 200 day simple moving average is $53.07.

Corteva (NYSE:CTVA - Get Free Report) last released its quarterly earnings results on Wednesday, May 1st. The company reported $0.89 earnings per share for the quarter, beating the consensus estimate of $0.79 by $0.10. Corteva had a net margin of 3.32% and a return on equity of 6.68%. The business had revenue of $4.49 billion for the quarter, compared to analysts' expectations of $4.65 billion. During the same quarter in the previous year, the business posted $1.16 earnings per share. The firm's revenue for the quarter was down 8.0% compared to the same quarter last year. Research analysts predict that Corteva, Inc. will post 2.8 EPS for the current fiscal year.

Corteva Announces Dividend

The company also recently disclosed a quarterly dividend, which was paid on Tuesday, June 18th. Shareholders of record on Tuesday, June 4th were given a dividend of $0.16 per share. The ex-dividend date was Tuesday, June 4th. This represents a $0.64 annualized dividend and a yield of 1.22%. Corteva's payout ratio is 81.01%.

Insiders Place Their Bets

In other Corteva news, insider Samuel R. Eathington sold 31,686 shares of the firm's stock in a transaction on Thursday, May 9th. The stock was sold at an average price of $57.64, for a total transaction of $1,826,381.04. Following the completion of the transaction, the insider now owns 53,854 shares of the company's stock, valued at $3,104,144.56. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link. In other news, insider Samuel R. Eathington sold 31,686 shares of the business's stock in a transaction that occurred on Thursday, May 9th. The stock was sold at an average price of $57.64, for a total value of $1,826,381.04. Following the sale, the insider now directly owns 53,854 shares of the company's stock, valued at approximately $3,104,144.56. The sale was disclosed in a legal filing with the SEC, which is accessible through the SEC website. Also, SVP Cornel B. Fuerer sold 39,736 shares of the firm's stock in a transaction that occurred on Tuesday, May 14th. The shares were sold at an average price of $57.41, for a total value of $2,281,243.76. Following the transaction, the senior vice president now directly owns 126,628 shares of the company's stock, valued at approximately $7,269,713.48. The disclosure for this sale can be found here. In the last quarter, insiders have sold 83,556 shares of company stock worth $4,795,016. Company insiders own 0.20% of the company's stock.

Corteva Profile

Corteva, Inc operates in the agriculture business. It operates through two segments, Seed and Crop Protection. The Seed segment develops and supplies advanced germplasm and traits that produce optimum yield for farms. It offers trait technologies that enhance resistance to weather, disease, insects, and herbicides used to control weeds, as well as food and nutritional characteristics.